$SLXP Company News SP shifts to ‘good news is good

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2013 at 12:17 PM

$SLXP Company News

S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 6:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 6:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 10:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 9:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 11:02 p.m. March 21, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 4:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 5:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 10:44 a.m. Oct. 7, 2011 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:46 p.m. Feb. 24, 2011 - Kate Gibson
Salix takes center stage in drug-stock trading 12:53 p.m. Feb. 24, 2011 - Val Brickates Kennedy
Salix plunges on FDA setback 10:14 a.m. Feb. 24, 2011 - Val Brickates Kennedy
European drug stocks need a shot in the arm 2:41 a.m. Jan. 13, 2011 - Simon Kennedy
Weak economic data chip away at the technicals 10:00 a.m. Aug. 19, 2010 - Michael Ashbaugh
Thursday's biggest gaining and declining stocks 3:52 p.m. March 25, 2010 - MarketWatch
Genzyme, Poniard drop; Salix, BioMarin jump 12:48 p.m. March 25, 2010 - Val Brickates Kennedy
Now is a good time to buy stocks 12:01 a.m. March 12, 2010 - Kevin Marder

Progenics: Investors Should Remain Cautious Heading Into The Relistor Panel 9:10 a.m. Dec. 5, 2013 - Seeking Alpha
Valeant, Akorn Power Drugmakers Up IBD Industry Ranks 4:59 p.m. Dec. 3, 2013 - Investors Business Daily
Salix Commences Cash Tender Offer for Outstanding Shares of Santarus at $32.00/Share 6:04 a.m. Dec. 3, 2013 - benzinga.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Investors Expect too Much of Salix 6:00 a.m. Dec. 2, 2013 - TheStreet.com
Jazz, Salix Secure Drugmakers' Hold On Leadership 4:49 p.m. Nov. 21, 2013 - Investors Business Daily
2013's Big Winners Having A Rough Week 3:28 a.m. Nov. 21, 2013 - Seeking Alpha
Salix Receives FDA CDRH Approval for Additional Injection Techniques for Deflux 6:04 a.m. Nov. 18, 2013 - benzinga.com
Santarus: To Hold Or Take Profits Now? 8:40 p.m. Nov. 16, 2013 - Seeking Alpha
New Lifetime High Today: Salix Pharmaceuticals (SLXP) 9:46 a.m. Nov. 15, 2013 - TheStreet.com
Narrower Q3 Loss at Progenics - Analyst Blog 9:50 a.m. Nov. 14, 2013 - Zacks.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Salix Pharmaceuticals - Fresh Highs On The Santaurus Deal 3:03 p.m. Nov. 11, 2013 - Seeking Alpha
Narrower-than-Expected Loss at ArQule - Analyst Blog 11:40 a.m. Nov. 11, 2013 - Zacks.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
What Does Salix Really Want With Santarus, And Should You Buy? 3:27 a.m. Nov. 11, 2013 - Seeking Alpha
Salix Pharmaceuticals: Santarus Acquisition Fortifies Position In Maturing Gastrointestinal Therapeutics Market 1:42 a.m. Nov. 11, 2013 - Seeking Alpha

Salix Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Santarus 7:01 a.m. Dec. 10, 2013 - BusinessWire
District Court Ruling, Cash Tender Offers, Celebration Events, Conference Presentations, and Repurchase Programs - Research Report on AstraZeneca, Salix, Health Net, Volcano and Portola 8:00 a.m. Dec. 9, 2013 - PR Newswire
Salix Pharmaceuticals Commences Cash Tender Offer for All Outstanding Shares of Santarus 7:01 a.m. Dec. 3, 2013 - BusinessWire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance 8:00 a.m. Nov. 21, 2013 - PR Newswire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection With Sale of the Company to Salix Pharmaceuticals, Ltd. -- SNTS 2:59 p.m. Nov. 18, 2013 - GlobeNewswire
Salix Announces Approval of Additional Injection Techniques for Deflux(R) 7:00 a.m. Nov. 18, 2013 - BusinessWire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Financial Results, New Appointments, and Stock Price Movements - Research Report on Salix Pharmaceuticals, Cigna, St. Jude Medical, Zimmer, and CareFusion 8:00 a.m. Nov. 13, 2013 - PR Newswire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 12:31 p.m. Nov. 11, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc. 11:31 a.m. Nov. 11, 2013 - PR Newswire
Critical Alerts For Salix Pharmaceuticals, Endo Pharmaceuticals, Nektar Therapeutics, Riverbed Technology, and Ubiquiti Networks Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Nov. 8, 2013 - PR Newswire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Nov. 8, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Nov. 8, 2013 - PR Newswire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Nov. 8, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Nov. 8, 2013 - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Nov. 8, 2013 - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Nov. 8, 2013 - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Nov. 8, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...